“…Studies performed with aminoglycosides have either been prospective studies in which a baseline period was followed by an extensive usage period of one aminoglycoside (7,(14)(15)(16), usually amikacin, or retrospective studies reporting the frequency of aminoglycoside resistance among clinical isolates over several years (17,18). The majority of these studies have demonstrated a clear relationship between the use of gentamicin, tobramycin and kanamycin, and bacterial resistance (7,(14)(15)(16). However, with amikacin, several studies have not shown a relationship between amikacin use and amikacin resistance (7,(14)(15)(16), while other studies have reported increased amikacin resistance with increased amikacin use (17,18).…”